Unknown OBSERVATIONAL NCT01249066

Expression of AMP-activated Protein Kinase (AMPK) Protein in Lung Adenocarcinoma

Sponsor: China Medical University Hospital

Updated 6 times since 2017 Last updated: Nov 26, 2010 Started: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Lung Adenocarcinoma, this trial is ongoing. The trial is conducted by China Medical University Hospital and has accumulated 6 data snapshots since 2010. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Unknown Status NA

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

China Medical University Hospital

Data source: China Medical University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Taichung, Taiwan